{"id":814861,"date":"2025-02-19T08:40:45","date_gmt":"2025-02-19T13:40:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/"},"modified":"2025-02-19T08:40:45","modified_gmt":"2025-02-19T13:40:45","slug":"annovis-to-host-patients-live-forum-on-february-27-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/","title":{"rendered":"Annovis to Host Patients\u2019 Live Forum on February 27, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MALVERN, Pa., Feb.  19, 2025  (GLOBE NEWSWIRE) &#8212; via IBN \u2013 Annovis Bio, Inc. (NYSE: ANVS) \u00a0(&#8220;Annovis&#8221; or the &#8220;Company&#8221;), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), will host a live webcast where CEO Maria Maccecchini, Ph.D., will answer questions from patients, caregivers, and families about the Company\u2019s clinical trials and future plans.<\/p>\n<p>\n        <b>Webcast Details<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:0in;margin-bottom:8pt\">Event:      Annovis Patients\u2019 Forum: Your Questions Answered<\/li>\n<li style=\"margin-top:0in;margin-bottom:8pt\">Date:      February 27, 2025<\/li>\n<li style=\"margin-top:0in;margin-bottom:8pt\">Time:      4:30 PM EST<\/li>\n<li style=\"margin-top:0in;margin-bottom:8pt\">Registration:      <a href=\"https:\/\/zoom.us\/webinar\/register\/WN_bhAzmfQPTgiFP3WaN9URoA#\/registration\" rel=\"nofollow\" target=\"_blank\">Click      here to register<\/a><\/li>\n<\/ul>\n<p>During the webcast, Dr. Maccecchini will provide updates on the ongoing Phase 3 AD trial, plans for the Phase 3 PD and Open Label Extension studies, and patient communication strategies. The webcast will include a short presentation highlighting recent achievements followed by a Q&amp;A session. Attendees are encouraged to submit their questions in advance to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8-_Mad6QvkjDMWyQvvuZ0fjHBV5MLkp9hwE6HCNmf688NEUkAv801QRSOD7HRudVTh0a-TbcCjbgefnaVDjLRv6XxysdLi0lBz7LylMVtjEM1-B_JsmSrXREyGLbTBrK\" rel=\"nofollow\" target=\"_blank\">clinicaltrials@annovisbio.com<\/a>.<\/p>\n<p>This event is open to all but is specifically designed for patients, families, and caregivers. Annovis regularly receives questions from current and prospective patients, and this forum aims to address as many as possible while providing a clear update on our work. Patients are at the heart of our mission, and we remain committed to transparency with our community.<\/p>\n<p>\n        <b>About Annovis<\/b><br \/>\n        <br \/>Headquartered in Malvern, Pennsylvania, Annovis is dedicated to addressing neurodegeneration in diseases such as AD and PD. The company\u2019s innovative approach targets multiple neurotoxic proteins, aiming to restore brain function and improve the quality of life for patients. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uHIeAq5JX8cXPGCGS7gyYp_PIqgbjpt2nbgt-Jeawt_tRUdgu87AQcIvdtIbmuHdmesdeUJzix4AwxRssJmgm_OSOgTzjXS9qTrbDrk9DNc=\" rel=\"nofollow\" target=\"_blank\">www.annovisbio.com<\/a> and follow us on LinkedIn, YouTube, and X.<\/p>\n<p>\n        <b>Investor Alerts<\/b><br \/>\n        <br \/>Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for Email Alerts at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=69-CA39jNjtLUjCGSh5TQQ50QoYuiiaQ6V41GJII4DeKqCiYrWZD5zLZ1z-amYeiqsvtc6FVPymw-NwzjQsNgzyu56_h3YbU_UlIlh2dkjdqvyq5-Xk7j-dB7LzyadpHvyQNqlYLzxznKQPbJlDA_w==\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.annovisbio.com\/email-alerts<\/a>. Additionally, we invite you to explore our updated investor website, which provides comprehensive access to company news, financial reports, and other key information.<\/p>\n<p>\n        <b>Forward-Looking Statements<\/b><br \/>\n        <br \/>This press release contains forward-looking statements under the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements relate to the Company\u2019s clinical trials, including patient enrollment, the efficacy and safety of Buntanetap, and expected outcomes. Actual results may differ due to various risks and uncertainties, including those outlined in the Company\u2019s SEC filings under \u201cRisk Factors\u201d in its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update forward-looking statements except as required by law.<\/p>\n<p>\n        <b>Contact Information:<\/b><br \/>\n        <br \/>Annovis Bio Inc.<br \/>101 Lindenwood Drive<br \/>Suite 225<br \/>Malvern, PA 19355<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uHIeAq5JX8cXPGCGS7gyYro57e4vyJBejxYu3FFAksdRlvh6xkJjdXl9p1lGL2w0-VvfPpCmM9oBK4mvotk1cYQFYI4aC8yT7YCX7dVTxEY=\" rel=\"nofollow\" target=\"_blank\">www.annovisbio.com<\/a><\/p>\n<p>\n        <b>Investor Contact:<\/b><br \/>\n        <br \/>Scott McGowan<br \/>InvestorBrandNetwork (IBN)<br \/>Phone: 310.299.1717<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AwTrVbqjomlElSMRI3J554s73WQngkWOW8G_fGJ5oV1xq06yJzV2WXkDqxRY5SC00AAbkBkgezyOOF54Z1Yi8QCLt2TIKZPjRTjOd_V4hH8=\" rel=\"nofollow\" target=\"_blank\">ir@annovisbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTY2ODFjOTgtNjhmMC00NmQzLTgxMzctYjk4MTRjYTFjYWQ2LTUwMDA3ODQ2NQ==\/tiny\/Annovis-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; via IBN \u2013 Annovis Bio, Inc. (NYSE: ANVS) \u00a0(&#8220;Annovis&#8221; or the &#8220;Company&#8221;), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), will host a live webcast where CEO Maria Maccecchini, Ph.D., will answer questions from patients, caregivers, and families about the Company\u2019s clinical trials and future plans. Webcast Details Event: Annovis Patients\u2019 Forum: Your Questions Answered Date: February 27, 2025 Time: 4:30 PM EST Registration: Click here to register During the webcast, Dr. Maccecchini will provide updates on the ongoing Phase 3 AD trial, plans for the Phase 3 PD and Open Label Extension studies, and patient communication strategies. The webcast &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Annovis to Host Patients\u2019 Live Forum on February 27, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-814861","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Annovis to Host Patients\u2019 Live Forum on February 27, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annovis to Host Patients\u2019 Live Forum on February 27, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; via IBN \u2013 Annovis Bio, Inc. (NYSE: ANVS) \u00a0(&#8220;Annovis&#8221; or the &#8220;Company&#8221;), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), will host a live webcast where CEO Maria Maccecchini, Ph.D., will answer questions from patients, caregivers, and families about the Company\u2019s clinical trials and future plans. Webcast Details Event: Annovis Patients\u2019 Forum: Your Questions Answered Date: February 27, 2025 Time: 4:30 PM EST Registration: Click here to register During the webcast, Dr. Maccecchini will provide updates on the ongoing Phase 3 AD trial, plans for the Phase 3 PD and Open Label Extension studies, and patient communication strategies. The webcast &hellip; Continue reading &quot;Annovis to Host Patients\u2019 Live Forum on February 27, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T13:40:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Annovis to Host Patients\u2019 Live Forum on February 27, 2025\",\"datePublished\":\"2025-02-19T13:40:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/\"},\"wordCount\":430,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/\",\"name\":\"Annovis to Host Patients\u2019 Live Forum on February 27, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==\",\"datePublished\":\"2025-02-19T13:40:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-host-patients-live-forum-on-february-27-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annovis to Host Patients\u2019 Live Forum on February 27, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annovis to Host Patients\u2019 Live Forum on February 27, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/","og_locale":"en_US","og_type":"article","og_title":"Annovis to Host Patients\u2019 Live Forum on February 27, 2025 - Market Newsdesk","og_description":"MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; via IBN \u2013 Annovis Bio, Inc. (NYSE: ANVS) \u00a0(&#8220;Annovis&#8221; or the &#8220;Company&#8221;), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), will host a live webcast where CEO Maria Maccecchini, Ph.D., will answer questions from patients, caregivers, and families about the Company\u2019s clinical trials and future plans. Webcast Details Event: Annovis Patients\u2019 Forum: Your Questions Answered Date: February 27, 2025 Time: 4:30 PM EST Registration: Click here to register During the webcast, Dr. Maccecchini will provide updates on the ongoing Phase 3 AD trial, plans for the Phase 3 PD and Open Label Extension studies, and patient communication strategies. The webcast &hellip; Continue reading \"Annovis to Host Patients\u2019 Live Forum on February 27, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-19T13:40:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Annovis to Host Patients\u2019 Live Forum on February 27, 2025","datePublished":"2025-02-19T13:40:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/"},"wordCount":430,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/","name":"Annovis to Host Patients\u2019 Live Forum on February 27, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==","datePublished":"2025-02-19T13:40:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDQ5NCM2NzU2NzE0IzUwMDA3ODQ2NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-host-patients-live-forum-on-february-27-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Annovis to Host Patients\u2019 Live Forum on February 27, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=814861"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814861\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=814861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=814861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=814861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}